For: | Yang M, Zhang CY. Diagnostic biomarkers for pancreatic cancer: An update. World J Gastroenterol 2021; 27(45): 7862-7865 [PMID: 34963749 DOI: 10.3748/wjg.v27.i45.7862] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v27/i45/7862.htm |
Number | Citing Articles |
1 |
Melissa M. Elder, Yves Paul Vincent Mbous, Toni Marie Rudisill, George A. Kelley. Screening for pancreatic cancer among smokers as high-risk individuals: Systematic review and meta-analysis of prospective cohort studies. Health Sciences Review 2024; 13: 100203 doi: 10.1016/j.hsr.2024.100203
|
2 |
Safia Samir, Mohamed El-Ashry, Waleed Soliman, Marwa Hassan. Urinary biomarkers analysis as a diagnostic tool for early detection of pancreatic adenocarcinoma: Molecular quantification approach. Computational Biology and Chemistry 2024; 112: 108171 doi: 10.1016/j.compbiolchem.2024.108171
|
3 |
Chun-Ye Zhang, Shuai Liu, Ming Yang. Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options. World Journal of Gastroenterology 2022; 28(48): 6827-6845 doi: 10.3748/wjg.v28.i48.6827
|
4 |
Sophia G. Kisling, Pranita Atri, Ashu Shah, Jesse L. Cox, Sunandini Sharma, Lynette M. Smith, Dario Ghersi, Surinder K. Batra. A Novel HOXA10-Associated 5-Gene–Based Prognostic Signature for Stratification of Short-term Survivors of Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research 2023; 29(18): 3759 doi: 10.1158/1078-0432.CCR-23-0825
|
5 |
Viviana Cortiana, Rabab Hunaid Abbas, Harshal Chorya, Jade Gambill, Diksha Mahendru, Chandler H. Park, Yan Leyfman. Personalized Medicine in Pancreatic Cancer: The Promise of Biomarkers and Molecular Targeting with Dr. Michael J. Pishvaian. Cancers 2024; 16(13): 2329 doi: 10.3390/cancers16132329
|
6 |
Zahra Yousefli, Nilofar Rafiee, Tanin Nourollahian, Amirreza Alipour, Zahra Haghshenas, Muhammad Islampanah, Majid Khazaei, Hamid Fiuji, Seyed Mahdi Hassanian, Gordon A Ferns, Elham Nazari, Amir Avan. Recent Advances of Circulating Biomarkers with Potential Diagnostic, Prognostic, and Therapeutic Value in Pancreatic Cancer; Limitations of Clinical Application.. Pathology - Research and Practice 2025; : 156045 doi: 10.1016/j.prp.2025.156045
|
7 |
Yu Chen, Jialun Wang, Qiyuan Guo, Xihan Li, Xiaoping Zou. Identification of MYEOV-Associated Gene Network as a Potential Therapeutic Target in Pancreatic Cancer. Cancers 2022; 14(21): 5439 doi: 10.3390/cancers14215439
|
8 |
Fatemeh Tajik, Fahimeh Fattahi, Fereshteh Rezagholizadeh, Behnaz Bouzari, Pegah Babaheidarian, Masoud Baghai Wadji, Zahra Madjd. Nuclear overexpression of DNA damage-inducible transcript 4 (DDIT4) is associated with aggressive tumor behavior in patients with pancreatic tumors. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-46484-3
|
9 |
Abinaya Elango, Vineeta Debbie Nesam, Padmaja Sukumar, Infancia Lawrence, Arunkumar Radhakrishnan. Postbiotic butyrate: role and its effects for being a potential drug and biomarker to pancreatic cancer. Archives of Microbiology 2024; 206(4) doi: 10.1007/s00203-024-03914-8
|
10 |
Chun-Ye Zhang, Shuai Liu, Ming Yang. Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression. World Journal of Gastrointestinal Oncology 2022; 14(8): 1456-1468 doi: 10.4251/wjgo.v14.i8.1456
|
11 |
Amir Sherchan, Feng Jin, Bhakti Sherchan, Sujit Kumar Mandal, Binit Upadhaya Regmi, Ranita Ghising, Sandesh Raj Upadhaya, Bishnu Gautam, Dipendra Pathak, Maoquan Li. Clinical significance of risk factor analysis in pancreatic cancer by using supervised model of machine learning. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1551926
|
12 |
Qian Zhao, Yan Wang, Tianyu Huo, Furong Li, Lu Zhou, Yongliang Feng, Zhigang Wei. Exploration of Risk Factors for Pancreatic Cancer and Development of a Clinical High-Risk Group Rating Scale. Journal of Clinical Medicine 2023; 12(1): 358 doi: 10.3390/jcm12010358
|
13 |
Luoluo Wang, Shuping Zhou, Yi Ruan, Xiang Wu, Xueming Zhang, Yi Li, Dongjian Ying, Yeting Lu, Yuan Tian, Gong Cheng, Jing Zhang, Kaiji Lv, Xinhua Zhou. Hypoxia-Challenged Pancreatic Adenocarcinoma Cell-Derived Exosomal circR3HCC1L Drives Tumor Growth Via Upregulating PKM2 Through Sequestering miR-873-5p. Molecular Biotechnology 2025; 67(2): 762 doi: 10.1007/s12033-024-01091-z
|